CRISPR and crRNAs
CRISPR/Cas9 Genome Editing
CRISPR
The Antiviral System of Bacteria and Archaea: CRISPR
Homologous Recombination
Caspases
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 11, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
Gianna Stella1, Luciano Marraffini2
1Laboratory of Bacteriology, The Rockefeller University, New York, NY 10065, USA; Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
This review explores how prokaryotic immune systems, specifically Type III CRISPR-Cas, defend against viral invaders. Beyond the main Cas10 protein, researchers examine how secondary molecules and enzymes regulate immune responses to ensure effective protection against bacteriophages and plasmids.
Area of Science:
Background:
Prokaryotic organisms face constant threats from viral invaders like bacteriophages and plasmids. These microbes developed sophisticated immune mechanisms to survive such environmental pressures. Type III CRISPR-Cas loci represent a highly prevalent class of these adaptive defense systems. While the Cas10 effector complex serves as a primary recognition unit, its full functional scope remains under active investigation. Prior research has shown that this complex coordinates multiple enzymatic activities upon identifying foreign genetic material. However, the broader regulatory network surrounding these systems is not fully understood. That uncertainty drove interest in identifying auxiliary components that modulate immune signaling. No prior work had resolved the complete interplay between these secondary effectors and the primary complex.
Purpose Of The Study:
The aim of this review is to examine the functional landscape of prokaryotic immune systems beyond the canonical effector. Researchers seek to understand how these systems achieve high levels of complexity. The study addresses the specific problem of how secondary components modulate immune signaling. This motivation stems from the need to map the full range of defense activities. The authors investigate how ancillary nucleases contribute to the overall immune response. They also explore the regulatory mechanisms governing cyclic oligoadenylate production. Furthermore, the work clarifies the role of CRISPR-associated proteases in responding to phage infection. This review provides a synthesis of current knowledge to guide future investigations into these intricate molecular networks.
Main Methods:
The review approach involves a systematic synthesis of recent literature regarding prokaryotic defense mechanisms. Authors examine data concerning the functional diversity of immune components beyond the canonical complex. They evaluate experimental findings related to ancillary nucleases and their sensing capabilities. The study methodology includes analyzing the regulatory roles of ring nucleases in signaling pathways. Researchers also investigate the biochemical properties of CRISPR-associated proteases. This review approach integrates structural and functional studies to map the immune network. The authors compare different experimental models to identify common regulatory themes. They synthesize evidence from diverse studies to provide a comprehensive overview of these complex systems.
Main Results:
Key findings from the literature indicate that immune systems utilize cyclic oligoadenylates as second messengers. These molecules activate CARF-domain effectors to initiate a robust defense response. The literature shows that ancillary nucleases provide protection by sensing these signaling molecules. Studies reveal that ring nucleases play a role in regulating the production of cyclic oligoadenylates. Research demonstrates that CRISPR-associated proteases facilitate a transcriptional response during viral infection. The findings highlight the Craspase complex as a significant mediator of this response. Data suggest that these systems coordinate multiple enzymatic activities to neutralize invaders. The literature confirms that immune defense extends beyond the activity of the primary Cas10 complex.
Conclusions:
The authors synthesize evidence regarding the diverse regulatory landscape of prokaryotic immunity. They highlight how ancillary nucleases provide defense by detecting specific signaling molecules. This review clarifies the role of ring nucleases in controlling the duration of immune activation. The researchers propose that CRISPR-associated proteases facilitate a sophisticated transcriptional response to infection. They emphasize that the Craspase complex functions as a key mediator in these pathways. The synthesis suggests that these systems operate through highly integrated multi-component networks. These findings imply that immune regulation extends far beyond the canonical effector complex. The review provides a comprehensive framework for understanding the complexity of these adaptive defense mechanisms.
The system utilizes a Cas10 complex that recognizes RNA guides. This recognition triggers single-stranded DNA degradation, synthesis of cyclic oligoadenylates, and target RNA cleavage. The researchers propose these activities work in concert to neutralize invading bacteriophages and plasmids.
Craspase is a CRISPR-associated protease. The authors describe its role in orchestrating a transcriptional response during phage infection. This component differs from ring nucleases, which primarily regulate the production of cyclic oligoadenylates.
Ancillary nucleases are necessary for defense because they sense cyclic oligoadenylates. This sensing mechanism allows the cell to respond to the presence of invaders. In contrast, ring nucleases act to limit the signaling cascade by degrading these molecules.
Cyclic oligoadenylates serve as second messengers. They activate CARF-domain effectors to initiate downstream immune responses. This signaling molecule is distinct from the RNA guides used for initial target recognition.
The researchers measure the activity of ring nucleases by their ability to degrade cyclic oligoadenylates. This phenomenon regulates the immune response duration. This measurement differs from assessing the cleavage of target RNA by the Cas10 complex.
The authors propose that the immune response is not limited to the Cas10 complex. They suggest that auxiliary proteins and proteases provide a layered defense. This perspective contrasts with earlier models that focused solely on the canonical effector.